Cefiderocol use for the treatment of infections by carbapenem-resistant Gram-negative bacteria: an Italian multicentre real-life experience.
Matteo PiccicaMichele SpinicciAnnarita BottaVincenzo BiancoFilippo LagiLucia GrazianiAlessandro FaragonaRoberto ParrellaTommaso GianiAndrea BartoliniGianluca MorroniMariano BernardoGian Maria RossoliniMarcello TavioAndrea GiacomettiAlessandro BartoloniPublished in: The Journal of antimicrobial chemotherapy (2023)
Real-life data confirm that cefiderocol is a promising option against carbapenem-resistant Gram-negative infections, even as monotherapy.